Breakthrough Medicine for Neurological Disorders

Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system.

 

shutterstock_396756052_dark.jpg
 
 

Technology

Convelo Therapeutics scientists have developed an innovative platform to identify novel candidate treatments capable of directly stimulating stem cells in the central nervous system to form new myelin. 

 
 
EM_dark.png
 
 
 
 
 
 
180517CTGroupShots0005_R.jpg